Modifier genetics in zebrafish identify Chk1 and an associated survival pathway as targets for pharmacotherapy of MDS/AML with P53 mutations.

Samuel Sidi, Andreas T. Hagen, Richard Kennedy, Shintaro Imamura, Shuji Kishi, John Kanki, Alan D'Andrea, A. Thomas Look

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)416A-416A
Number of pages1
Issue number11
Publication statusPublished - 16 Nov 2006
Event48th Annual Meeting of the American-Society-of-Hematology - Orlando, United States
Duration: 09 Dec 200612 Dec 2006

Cite this